首页> 外文期刊>Nanotechnology >Fabrication of modified and functionalized polycaprolactone nanofibre scaffolds for vascular tissue engineering
【24h】

Fabrication of modified and functionalized polycaprolactone nanofibre scaffolds for vascular tissue engineering

机译:用于血管组织工程的改性和功能化聚己内酯纳米纤维支架的制备

获取原文
获取原文并翻译 | 示例
           

摘要

Electrospun polymer nanofibres were originally developed for their durability and resistance to all forms of degradation and biodegradation. Some polymer nanofibres are biocompatible and biodegradable and therefore suitable for replacement of structurally or physiologically deficient tissues and organs in humans. Here, biocompatible polycaprolactone (PCL) nanofibre scaffolds modified with collagen types I and III were used for vascular tissue engineering. Coronary artery smooth muscle cells (SMCs) were grown on PCL nanofibres, modified PCL/collagen biocomposite nanofibres and collagen nanofibres. The results show that the modified PCL/collagen biocomposite nanofibre scaffolds provide required mechanical properties for regulation of normal cell function in vascular tissue engineering.
机译:电纺聚合物纳米纤维最初是由于其耐用性和对各种形式的降解和生物降解的抵抗力而开发的。一些聚合物纳米纤维具有生物相容性和生物可降解性,因此适合替代人体中结构或生理上缺乏的组织和器官。在这里,使用I型和III型胶原蛋白修饰的生物相容性聚己内酯(PCL)纳米纤维支架被用于血管组织工程。冠状动脉平滑肌细胞(SMCs)在PCL纳米纤维,改性的PCL /胶原生物复合纳米纤维和胶原蛋白纳米纤维上生长。结果表明,改性的PCL /胶原生物复合纳米纤维支架为血管组织工程中正常细胞功能的调节提供了所需的机械性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号